News

Krusteaz goes gluten-free

BY Ryan Chavis

SEATTLE — Krusteaz — a maker of baking, pancake and waffle mixes — on Tuesday debuted its first line of gluten-free products, which will be available at most grocery stores across the country. The company is confident that the gluten-free items will be just as tasty as its traditional counterparts — so much so that it will provide a refund to any consumer who isn't satisfied with the mixes.
 
"We created our gluten free line because we believe that if you don't eat gluten, you shouldn't have to sacrifice taste and quality," said Andy Heily, SVP sales and marketing, Krusteaz. "We believe these products are so good that consumers will be shocked they are eating gluten free."
 
The line includes:
 
  • Gluten Free Buttermilk Pancake Mix;
  • Gluten Free Blueberry Muffin Mix;
  • Gluten Free Honey Cornbread & Muffin Mix; and
  • Gluten Free Double Chocolate Brownie Mix.
Krusteaz gluten-free mixes are available for $4.49 each. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Boehringer Ingelheim’s Ofev caps now available

BY Ryan Chavis

RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals on Monday announced that Ofev (nintedanib) capsules are now available in the United States. Ofev was approved by the Food and Drug Administration on Oct. 15 to treat idiopathic pulmonary fibrosis. IPF is a condition in which the lungs scar over time. As a result of the scarring, patients with IPF experience shortness of breath, cough and have trouble taking part in physical activities. The disease is rare, fatal and affects nearly 132,000 Americans, according to the company.
 
To support the launch of Ofev, Boehringer Ingelheim established Open Doors, a patient support program that provides financial and nursing support services. One of the goals of Open Doors is to help patients who are prescribed the medicine gain rapid, affordable access to it. 
 
“We are proud to be able to offer IPF patients an effective therapy for this rare and fatal disease, together with comprehensive programs and services to support patients and healthcare providers as they begin therapy with Ofev,” said Tunde Otulana, M.D., a pulmonologist and SVP, clinical development and medical affairs at Boehringer Ingelheim. “Bringing a new treatment such as Ofev to patients when there is such significant unmet need is the result of many years of research and demonstrates our commitment to making a difference for patients with respiratory diseases.”
 
Ofev is available through specialty pharmacy distrubutors as well a select network of pharmacies. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Pirate’s Booty will set sail in iconic parade

BY Ryan Chavis

PARSIPPANY, N.J. — B&G Foods' Pirate's Booty brand will sail the high seas at the 88th Annual Macy's Thanksgiving Day Parade, the company announced. To celebrate the "Treasure Hunt" pirate ship float, Pirate's Booty will launch an online "Share Yarrr Thanksgiving Traditions" contest in the coming month for a chance to win a trip to New York to watch the iconic parade live. 
 
"As the grand schooner ship sets sail down the Parade route, millions of fans will join the Pirate's Booty Pirate and his first mate, Crunchy the Parrot, on an incredible holiday treasure hunt," said Amy Kule, executive producer of Macy's Thanksgiving Day Parade. "This wonderful pirate-themed creation is sure to entertain the scores of fans lining the streets of Manhattan and those gathered around television screens nationwide." 
 
To enter the "Share Yarrr Thanksgiving Traditions" contest — which takes place from Nov. 6 through Nov. 27 — consumers can set sail to Facebook.com/PiratesBooty. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?